End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.65 TWD | +2.47% | +11.89% | -29.88% |
06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
230M | - | - | - | - | - | |
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.91B |